B-Cell Lymphoma
Symptoms, Doctors, Treatments, Advances & More

B-Cell Lymphoma Overview

Save information for later
Sign Up

Learn About B-Cell Lymphoma

What is the definition of B-Cell Lymphoma?
B-cell lymphoma refers to types of non-Hodgkin lymphoma that are characterized by abnormalities of the "B-cells" (a type of white blood cell that makes antibodies to help fight infection). The condition may grow and spread slowly with few symptoms (also known as indolent lymphoma) or may be very aggressive with severe symptoms. When present, signs and symptoms may include swollen lymph nodes in the neck, armpit, or groin; abdominal pain; fatigue; fever; night sweats; and/or weight loss. The underlying cause of B-cell lymphoma is poorly understood. However, the condition can be associated with genetic abnormalities, environmental factors, viruses, immunodeficiency states, and connective-tissue disorders.
What are the alternative names for B-Cell Lymphoma?
  • B-cell lymphoma
  • Lymphoma, B-Cell
Who are the top B-Cell Lymphoma Local Doctors?
Elite in B-Cell Lymphoma
Dr. Julie M. Vose
Hematology | Oncology
Elite in B-Cell Lymphoma
Dr. Julie M. Vose
Hematology | Oncology
Referral may be required

Fred & Pamela Buffett Cancer Center - Nebraska Medical Center

505 S 45th St., 
Omaha, NE 
402-559-5600
Experience:
42+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Julie Vose is a Hematologist and an Oncologist practicing medicine in Omaha, Nebraska. She has been practicing medicine for over 42 years. Dr. Vose is rated as an Elite provider by MediFind in the treatment of B-Cell Lymphoma. She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Mantle Cell Lymphoma (MCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Elite in B-Cell Lymphoma
Elite in B-Cell Lymphoma
Referral may be required

Abramson Cancer Center Perelman 4th Floor West

3400 Civic Center Boulevard, West Pavilion, 4th Floor, 
Philadelphia, PA 
215-615-5858
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Stephen Schuster is a Hematologist practicing medicine in Philadelphia, Pennsylvania. Dr. Schuster is rated as an Elite provider by MediFind in the treatment of B-Cell Lymphoma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Schuster is board certified in Medical Oncology, 1989, Hematology, 1986, and Internal Medicine, 1984.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in B-Cell Lymphoma
Dr. Paolo Caimi
Hematology Oncology | Hematology | Oncology
Elite in B-Cell Lymphoma
Dr. Paolo Caimi
Hematology Oncology | Hematology | Oncology
Referral may be required

Cleveland Clinic Main Campus

10201 Carnegie Avenue, 
Cleveland, OH 
866-223-8100
Languages Spoken:
English, Spanish
See accepted insurances
Offers Telehealth

Paolo Caimi is a Hematologist Oncology specialist and a Hematologist practicing medicine in Cleveland, Ohio. Dr. Caimi is rated as an Elite provider by MediFind in the treatment of B-Cell Lymphoma. He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Caimi is board certified in American Board Of Internal Medicine, 2011.

View All Doctors
What are the latest B-Cell Lymphoma Clinical Trials?
Primary, Booster and Consolidation Multi-CAR-T Cell Therapy for the Treatment of Refractory B Cell Lymphomas
Primary, Booster and Consolidation Multi-CAR-T Cell Therapy for the Treatment of Refractory B Cell Lymphomas
Who is this study for: Child to adult patients with Primary B Cell Lymphoma
Enrollment Status: Recruiting
Publish Date: June 18, 2026
Intervention Type: Biological
Study Drug: 4S-Engineered CD19/CD20/CD22/CD70/PSMA/CD13/CD79b/GD2-Positive CAR-T Cells
Study Phase: Phase 1/Phase 2

Summary: This study aims to evaluate safety and efficacy of a combination of 4th generation chimeric antigen receptor gene-modified T cells targeting B cell surface molecules including CD19 and alternative CARTs as booster and consolidation treatment for patients with highly resistant B cell lymphomas, including primary mediastinal B cell lymphoma (PMBCL) and BCL involving central nervous system (CNS-BCL)....

Match to trials
Find the right clinical trials for you in under a minute
Get started
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, and/or Cancer
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, and/or Cancer
Enrollment Status: Recruiting
Publish Date: June 18, 2026

Summary: BACKGROUND: * A number of important scientific advances can be made through the study of blood, bone marrow, tumor, or other tissue samples from patients with HIV infection, infection with Kaposi s sarcoma associated herpesvirus (KSHV), infection with other oncogenic viruses, or cancer. * This protocol provides a mechanism to affect a variety of such studies. OBJECTIVES: -Acquisition of serum, cir...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center